Advances in drugs and vaccines hold great promise for reducing disease-related suffering, but the current R&D model often leads to high prices, limiting access and straining healthcare budgets. Critical areas like antibiotics and treatments for infectious diseases receive little investment due to low profitability. Can alternative approaches to R&D financing, organisation and regulation improve health outcomes?

Professor Moon will present findings from a five-year project on alternative innovation models, including case studies on pandemic preparedness, neglected diseases, rare diseases and antibiotics, while Professor John C.W. Lim will discuss regulatory frameworks in Singapore and ASEAN supporting pharmaceutical innovation.

Keynote speaker
Prof Suerie Moon (SingHealth Duke-NUS Global Health Institute and Centre for Outbreak Preparedness; Geneva Graduate Institute)
Guest speaker
Prof John CW Lim (SingHealth Duke-NUS Global Health Institute; Duke-NUS Centre of Regulatory Excellence)
Moderator
Asst Prof Tan-Koi Wei Chuen (Duke-NUS Centre of Regulatory Excellence)

Read the full recap

Download the event slides